CELLULAR, TISSUE, AND GENE THERAPIES ADVISORY COMMITTEE; NOTICE OF MEETING; ESTABLISHMENT OF A PUBLIC DOCKET; REQUEST FOR COMMENTS-BIOLOGICS LICENSE APPLICATION (BLA) 125827, FROM REPLIMUNE, INC. FOR

BLA filing and advisory committee meeting signal potential regulatory catalyst for Replimune product.